11/01/2011

ImmunoSite Technologies Allies with Goodwin Biotechnology Increasing Capabilities

Tags: , , , , ,

Working together, ImmunoSite Technologies and Goodwin Biotechnology companies offer enhanced abilities to develop, test and manufacture biopharmaceuticals

Share this:
  • Print
  • Digg
  • Facebook
  • email
  • LinkedIn
  • Twitter
Continue Reading


10/18/2011

ImmunoSite Technologies Aides in Curriculum Development for Employ Florida Banner Center

Tags:

Cell Culture Course helps Floridians enter, remain and advance in the workforce Full release click here. Fort Lauderdale, Fla. – October 18, 2011 – ImmunoSite Technologies (IST), LLC, a leading provider of immune monitoring services, has helped develop a Cell Culture Workshop that will be offered for the first time October 27 and 28 at [...]

Share this:
  • Print
  • Digg
  • Facebook
  • email
  • LinkedIn
  • Twitter
Continue Reading


09/27/2011

ImmunoSite Technologies Allies with Immudex for More Effective T Cell Response Monitoring

Tags: , , , , , , , , , ,

Working together, companies offer enhanced abilities to monitor immunotherapy response in vaccine and drug studies.

Share this:
  • Print
  • Digg
  • Facebook
  • email
  • LinkedIn
  • Twitter
Continue Reading


04/03/2011

ImmunoSite Technologies Provides Particle Testing Services to Beckman Coulter Customers

Tags: , , , , , , ,

IST employs a wide range of particle testing technologies

Leading provider of particle testing services now receives referrals of customers seeking particle characterization services from Beckman Coulter, Inc. Fort Lauderdale, Fla. – April 3, 2011 – ImmunoSite Technologies, LLC, a leading provider of immune monitoring services, is now receiving direct customer referrals for particle testing services from Beckman Coulter, Inc. as part of a [...]

Share this:
  • Print
  • Digg
  • Facebook
  • email
  • LinkedIn
  • Twitter
Continue Reading


12/29/2010

ImmunoSite Technologies develops quality assurance materials

ImmunoSite Technologies Has Been Working With The “CD4 Initiative” To Develop Quality Assurance Materials For Novel, Disposable, CD4 Point-Of-Care Test For Developing Nations The CD4 Initiative at Imperial College, London, funded by Bill and Melinda Gates Foundation grants, is nearing a major breakthrough in HIV/AIDS care by developing a simple, inexpensive CD4 point-of-care test specifically [...]

Share this:
  • Print
  • Digg
  • Facebook
  • email
  • LinkedIn
  • Twitter
Continue Reading